crofelemer 125 MG Delayed Release Oral Tablet [Mytesi]

RxNorm concept 1806878, branded drug (sbd). Prescribable name: Mytesi 125 MG Delayed Release Oral Tablet.

RxCUI: 1806878
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1806878 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

crofelemer 1364449

Other names

Mytesi 125 MG Delayed Release Oral Tablet

Related concepts

crofelemer 125 MG (SCDC, consists of)
crofelemer 125 MG [Mytesi] (SBDC, consists of)
Delayed Release Oral Tablet (DF, has dose form)
Mytesi (BN, has ingredient)
crofelemer 125 MG Delayed Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1806878 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1806878 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1806878. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.